Discontinuation vs. continuation of renin–angiotensin system inhibition before non-cardiac surgery: the SPACE trial

Abstract

Discontinuing RAS inhibitors before non-cardiac surgery did not reduce myocardial injury, and could increase the risk of clinically significant acute hypertension. These findings require confirmation in future studies.